Atlas Trials

Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART

Clinical trial NCT03706950 · UNKNOWN

Trial details

NCT number
NCT03706950
Sponsor
Viriom
Status
UNKNOWN
Study type
OBSERVATIONAL
HIV-1-infection
Start date
2018-03-15
Primary completion
2021-12-31
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.